Literature DB >> 16387811

Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: an acute echocardiographic study.

P-V Ennezat1, B Gal, C Kouakam, C Marquie, T LeTourneau, D Klug, D Lacroix, D Logeart, A Cohen-Solal, S Dennetière, E Van Belle, G Deklunder, P Asseman, P de Groote, S Kacet, T H LeJemtel.   

Abstract

OBJECTIVES: To assess non-invasively the acute effects of cardiac resynchronisation therapy (CRT) on functional mitral regurgitation (MR) at rest and during dynamic exercise.
METHODS: 21 patients with left ventricular (LV) systolic dysfunction and functional MR at rest, treated with CRT, were studied. Each patient performed a symptom-limited maximal exercise with continuous two dimensional Doppler echocardiography twice. The first exercise was performed with CRT; the second exercise was performed without CRT. Mitral regurgitant flow volume (RV), effective regurgitant orifice area (ERO) and LV dP/dt were measured at rest and at peak exercise.
RESULTS: CRT mildly reduced resting mitral ERO (mean 8 (SEM 2) v 11 (2) mm(2) without CRT, p = 0.02) and RV (13 (3) v 18 (3) ml without CRT, p = 0.03). CRT attenuated the spontaneous increase in mitral ERO and RV during exercise (1 (1) v 9 (2) mm(2), p = 0.004 and 1 (1) v 8 (2) ml, p = 0.004, respectively). CRT also significantly increased exercise-induced changes in LV dP/dt (140 (46) v 479 (112) mm Hg/s, p < 0.001).
CONCLUSION: Attenuation of functional MR, induced by an increase in LV contractility during dynamic exercise, may contribute to the beneficial clinical outcome of CRT in patients with chronic heart failure and LV asynchrony.

Entities:  

Mesh:

Year:  2005        PMID: 16387811      PMCID: PMC1861095          DOI: 10.1136/hrt.2005.071654

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

1.  Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies.

Authors:  S He; A A Fontaine; E Schwammenthal; A P Yoganathan; R A Levine
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

2.  Optimizing the AV delay in DDD pacemaker patients with high degree AV block: mitral valve Doppler versus impedance cardiography.

Authors:  M Kindermann; G Fröhlig; T Doerr; H Schieffer
Journal:  Pacing Clin Electrophysiol       Date:  1997-10       Impact factor: 1.976

3.  Mitral regurgitation: clinical patterns, pathophysiology and natural history.

Authors:  A Selzer; F Katayama
Journal:  Medicine (Baltimore)       Date:  1972-09       Impact factor: 1.889

4.  Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure.

Authors:  C S Maskin; R Forman; E H Sonnenblick; W H Frishman; T H LeJemtel
Journal:  Am J Cardiol       Date:  1983-01-01       Impact factor: 2.778

5.  A new method for estimating left ventricular dP/dt by continuous wave Doppler-echocardiography. Validation studies at cardiac catheterization.

Authors:  G S Bargiggia; C Bertucci; F Recusani; A Raisaro; S de Servi; L M Valdes-Cruz; D J Sahn; L Tronconi
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

6.  Determinants of pulmonary hypertension in left ventricular dysfunction.

Authors:  M Enriquez-Sarano; A Rossi; J B Seward; K R Bailey; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1997-01       Impact factor: 24.094

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

8.  Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure.

Authors:  J Kugler; C Maskin; W H Frishman; E H Sonnenblick; T H LeJemtel
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

9.  Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients.

Authors:  Hugues Bader; Stephane Garrigue; Stephane Lafitte; Sylvain Reuter; Pierre Jaïs; Michel Haïssaguerre; Jacques Bonnet; Jacques Clementy; Raymond Roudaut
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

10.  Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method.

Authors:  M Enriquez-Sarano; F A Miller; S N Hayes; K R Bailey; A J Tajik; J B Seward
Journal:  J Am Coll Cardiol       Date:  1995-03-01       Impact factor: 24.094

View more
  5 in total

Review 1.  Dynamic Secondary Mitral Regurgitation: Current Evidence and Challenges for the Future.

Authors:  Hirokazu Onishi; Masaki Izumo; Toru Naganuma; Sunao Nakamura; Yoshihiro J Akashi
Journal:  Front Cardiovasc Med       Date:  2022-04-25

2.  The use of exercise echocardiography in the evaluation of mitral regurgitation.

Authors:  Kibar Yared; Kaitlyn My-Tu Lam; Judy Hung
Journal:  Curr Cardiol Rev       Date:  2009-11

3.  Biventricular pacing: impact on exercise-induced increases in mitral insufficiency in patients with chronic heart failure.

Authors:  Klaus K Witte; Zion Sasson; Joan A Persaud; Robynn Jolliffe; Robert W Wald; John D Parker
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

4.  Left Ventricular Dyssynchrony and the Mitral Valve Apparatus: An Orchestra That Needs to Play in Sync.

Authors:  Robert A Levine; Yasufumi Nagata; Jacob P Dal-Bianco
Journal:  JACC Cardiovasc Imaging       Date:  2019-01-16

5.  Dynamic left ventricular dyssynchrony and severe mitral regurgitation caused by exercise: should we go beyond the guidelines?

Authors:  Emilie Laflamme; François Philippon; Kim O'Connor; Jean-François Sarrazin; Vincent Auffret; Vincent Chauvette; Michelle Dubois; Pierre Voisine; Sébastien Bergeron; Mario Sénéchal
Journal:  Int Med Case Rep J       Date:  2018-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.